Upstart Insider Trades: Option Exercises and Share Sales by Gu Paul
Rhea-AI Filing Summary
Gu Paul, Chief Technology Officer and director of Upstart Holdings, Inc. (UPST), reported option exercises and open-market sales on 09/02/2025. The reporting person exercised two employee stock options for 2,500 shares each at exercise prices of $3.80 and $8.88, increasing option-derived holdings. Concurrently, the reporting person sold 2,663 and 2,337 shares in separate transactions at weighted-average prices of $68.3518 and $68.9082, respectively. After these transactions the report shows beneficial ownership of 1,147,156 shares.
The Form 4 discloses the trades were effected under a Rule 10b5-1 trading plan adopted on May 21, 2025, notes certain holdings are restricted stock units, and confirms the reported options were fully vested and exercisable as of the transaction date.
Positive
- Trades were executed under a Rule 10b5-1 trading plan, indicating pre-established instructions and compliance with insider-trading protocols.
- Options exercised were fully vested, and the Form 4 discloses option exercise and RSU status, improving transparency of insider holdings.
Negative
- Insider sold 5,000 shares (2,663 and 2,337 shares) on 09/02/2025, which may be viewed negatively by some investors as insider selling.
- Weighted-average sale prices near $68.4 reduced the filer’s share count from 1,152,156 to 1,147,156, representing actual disposition of outstanding shares.
Insights
TL;DR: Officer exercised low-cost options and sold 5,000 shares under a 10b5-1 plan, leaving roughly 1.15 million shares beneficially owned.
The activity reflects routine insider option exercises and systematic disposition under a pre-established plan rather than ad hoc market selling. Exercises at $3.80 and $8.88 are substantially below the weighted-average sale prices near $68.4, realizing a large intrinsic gain per share for the reporting person. The report quantifies post-transaction ownership at 1,147,156 shares, providing investors transparency on insider holdings without signaling a change in corporate outlook.
TL;DR: Transactions were executed under a disclosed 10b5-1 plan and the filer certified option vesting—procedurally compliant disclosure.
The Form 4 explicitly states the trades were effected pursuant to a Rule 10b5-1 plan adopted May 21, 2025, and includes undertakings to provide breakdowns of mixed-price sales. It also identifies certain holdings as RSUs and confirms full vesting of the exercised options. These disclosures meet typical insider-reporting and governance transparency expectations.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Employee Stock Option (Right to buy) | 2,500 | $3.80 | $10K |
| Exercise | Employee Stock Option (Right to buy) | 2,500 | $8.88 | $22K |
| Exercise | Common Stock | 2,500 | $3.80 | $10K |
| Exercise | Common Stock | 2,500 | $8.88 | $22K |
| Sale | Common Stock | 2,663 | $68.3518 | $182K |
| Sale | Common Stock | 2,337 | $68.9082 | $161K |
Footnotes (1)
- The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2025. Certain of these securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.795 to $68.78. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.80 to $69.125. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. All of the shares subject to this option are fully vested and exercisable as of the date hereof.